Business Context and Reporting Period
Company: Harvard Bioscience, Inc. (HBIO)
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2025
Reporting Period: The filing announces financial results for the three and twelve months ended December 31, 2024.
Key Financial Metrics
The provided text is a cover sheet and index for the Form 8-K. It references a press release (Exhibit 99.1) containing the actual financial data but does not list specific figures within this document.
- Revenue, Profit, Cash Flow, Margins: Not provided in this text; contained in the referenced press release.
- Debt and Liquidity: Not provided in this text; contained in the referenced press release.
Material Changes
The filing text does not provide specific data regarding material changes versus prior periods. It only confirms the issuance of results for the period ended December 31, 2024.
Guidance, Outlook, and Management Commentary
Conference Call: Management scheduled a conference call for March 12, 2025, at 8:00 AM ET to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is furnished and not deemed "filed" under Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and FY 2024.
- Verify the details of the conference call held on March 12, 2025, for management commentary on future outlook.
- Check for any unusual items or one-time charges disclosed in the full press release text.
- Confirm if the company provided updated guidance for the current fiscal year during the call.